Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Chemoprevention is rarely used due to concerns about risks, side effects, and lack of clear guidelines.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Expressing the human vitamin D receptor in skin cells prevents hair loss in certain mice.

The nanoparticles show promise for cancer treatment and diagnosis with fewer side effects.

Repurposing existing drugs can quickly and cheaply find new treatments.

Androgen receptor expression is similar in affected and unaffected scalp areas in androgenetic alopecia.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

A new method was developed to accurately detect and measure 47 different drug ingredients in various products.

Finasteride, a medication, is being re-evaluated for its effects and uses.

The study successfully identified the structure of finasteride.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

Delta opioid receptors help regulate touch sensation by reducing neurotransmitter release in the spinal cord.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Compound 15a was effective in inhibiting 5α-reductase.

VEGFR-2 is active in hair follicles, sebaceous glands, sweat glands, and skin on the human scalp.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

The vitamin D receptor is essential for normal hair growth, even without its usual binding.

The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.